• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Differences in the predominance of lysosomal and autophagic pathologies between infants and adults with Pompe disease: implications for therapy.婴儿与成人间庞贝病溶酶体和自噬病理优势的差异:对治疗的启示。
Mol Genet Metab. 2010 Dec;101(4):324-31. doi: 10.1016/j.ymgme.2010.08.001. Epub 2010 Aug 7.
2
Murine muscle cell models for Pompe disease and their use in studying therapeutic approaches.用于庞贝病的小鼠肌肉细胞模型及其在研究治疗方法中的应用。
Mol Genet Metab. 2009 Apr;96(4):208-17. doi: 10.1016/j.ymgme.2008.12.012. Epub 2009 Jan 22.
3
Skeletal muscle pathology of infantile Pompe disease during long-term enzyme replacement therapy.长期酶替代治疗期间婴儿型庞贝病的骨骼肌病理学
Orphanet J Rare Dis. 2013 Jun 20;8:90. doi: 10.1186/1750-1172-8-90.
4
Autophagy and lysosomes in Pompe disease.庞贝病中的自噬与溶酶体
Autophagy. 2006 Oct-Dec;2(4):318-20. doi: 10.4161/auto.2984. Epub 2006 Oct 5.
5
Autophagy in skeletal muscle: implications for Pompe disease.骨骼肌中的自噬:对庞贝病的影响。
Int J Clin Pharmacol Ther. 2009;47 Suppl 1(Suppl 1):S42-7. doi: 10.5414/cpp47042.
6
Deconstructing Pompe disease by analyzing single muscle fibers: to see a world in a grain of sand..通过分析单个肌纤维解构庞贝氏病:从一粒沙中见世界。
Autophagy. 2007 Nov-Dec;3(6):546-52. doi: 10.4161/auto.4591. Epub 2007 Jun 15.
7
Enzyme replacement therapy in the mouse model of Pompe disease.庞贝氏病小鼠模型中的酶替代疗法。
Mol Genet Metab. 2003 Sep-Oct;80(1-2):159-69. doi: 10.1016/j.ymgme.2003.08.022.
8
Suppression of autophagy permits successful enzyme replacement therapy in a lysosomal storage disorder--murine Pompe disease.自噬抑制可使溶酶体贮积症——鼠 Pompe 病的酶替代治疗获得成功。
Autophagy. 2010 Nov;6(8):1078-89. doi: 10.4161/auto.6.8.13378.
9
Autophagy and mitochondria in Pompe disease: nothing is so new as what has long been forgotten.自噬和庞贝病中的线粒体:没有什么比被遗忘已久的东西更新了。
Am J Med Genet C Semin Med Genet. 2012 Feb 15;160C(1):13-21. doi: 10.1002/ajmg.c.31317. Epub 2012 Jan 17.
10
When more is less: excess and deficiency of autophagy coexist in skeletal muscle in Pompe disease.当多即少:庞贝病骨骼肌中自噬的过度与不足并存。
Autophagy. 2009 Jan;5(1):111-3. doi: 10.4161/auto.5.1.7293. Epub 2009 Jan 30.

引用本文的文献

1
Skeletal muscle effects of antisense oligonucleotides targeting glycogen synthase 1 in a mouse model of Pompe disease.在庞贝病小鼠模型中,靶向糖原合酶1的反义寡核苷酸对骨骼肌的影响。
Clin Transl Med. 2025 Apr;15(4):e70314. doi: 10.1002/ctm2.70314.
2
An analysis of Pompe newborn screening data: a new prevalence at birth, insight and discussion.庞贝氏症新生儿筛查数据分析:出生时的新患病率、见解与讨论
Front Pediatr. 2024 Jan 8;11:1221140. doi: 10.3389/fped.2023.1221140. eCollection 2023.
3
Therapeutic Options for the Management of Pompe Disease: Current Challenges and Clinical Evidence in Therapeutics and Clinical Risk Management.庞贝病治疗管理的治疗选择:治疗与临床风险管理中的当前挑战及临床证据
Ther Clin Risk Manag. 2022 Dec 13;18:1099-1115. doi: 10.2147/TCRM.S334232. eCollection 2022.
4
The Clinical Management of Pompe Disease: A Pediatric Perspective.庞贝氏病的临床管理:儿科视角
Children (Basel). 2022 Sep 16;9(9):1404. doi: 10.3390/children9091404.
5
Neuromuscular Development and Disease: Learning From and Models.神经肌肉发育与疾病:借鉴与模型
Front Cell Dev Biol. 2021 Oct 27;9:764732. doi: 10.3389/fcell.2021.764732. eCollection 2021.
6
Autophagy is affected in patients with hypokalemic periodic paralysis: an involvement in vacuolar myopathy?低钾型周期性瘫痪患者的自噬受到影响:是否涉及空泡性肌病?
Acta Neuropathol Commun. 2021 Jun 13;9(1):109. doi: 10.1186/s40478-021-01212-8.
7
Three-dimensional tissue-engineered human skeletal muscle model of Pompe disease.庞贝氏病的三维组织工程化人骨骼肌模型。
Commun Biol. 2021 May 5;4(1):524. doi: 10.1038/s42003-021-02059-4.
8
The Role of iPSC Modeling Toward Projection of Autophagy Pathway in Disease Pathogenesis: Leader or Follower.iPSC 模型在预测疾病发病机制中自噬途径的作用:领导者还是追随者。
Stem Cell Rev Rep. 2021 Apr;17(2):539-561. doi: 10.1007/s12015-020-10077-8. Epub 2020 Nov 27.
9
Applications for Induced Pluripotent Stem Cells in Disease Modelling and Drug Development for Heart Diseases.诱导多能干细胞在心脏病疾病建模和药物开发中的应用
Eur Cardiol. 2020 Feb 26;15:1-10. doi: 10.15420/ecr.2019.03. eCollection 2020 Feb.
10
DeepNEU: Artificially Induced Stem Cell (aiPSC) and Differentiated Skeletal Muscle Cell (aiSkMC) Simulations of Infantile Onset POMPE Disease (IOPD) for Potential Biomarker Identification and Drug Discovery.DeepNEU:用于潜在生物标志物鉴定和药物发现的婴儿型庞贝病(IOPD)的人工诱导干细胞(aiPSC)和分化骨骼肌细胞(aiSkMC)模拟。
Front Cell Dev Biol. 2019 Dec 6;7:325. doi: 10.3389/fcell.2019.00325. eCollection 2019.

本文引用的文献

1
A randomized study of alglucosidase alfa in late-onset Pompe's disease.一项针对晚发性庞贝病的阿糖苷酶 α 的随机研究。
N Engl J Med. 2010 Apr 15;362(15):1396-406. doi: 10.1056/NEJMoa0909859.
2
Pompe disease in infants: improving the prognosis by newborn screening and early treatment.婴儿庞贝病:通过新生儿筛查和早期治疗改善预后
Pediatrics. 2009 Dec;124(6):e1116-25. doi: 10.1542/peds.2008-3667.
3
Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants.免疫交叉反应物质状态会影响庞贝病婴儿的治疗效果。
Mol Genet Metab. 2010 Jan;99(1):26-33. doi: 10.1016/j.ymgme.2009.08.003.
4
Regulation mechanisms and signaling pathways of autophagy.自噬的调控机制与信号通路。
Annu Rev Genet. 2009;43:67-93. doi: 10.1146/annurev-genet-102808-114910.
5
Enzyme replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2: 12-month results of an observational clinical trial.阿糖苷酶α治疗晚发性糖原贮积症 2 型 44 例患者:观察性临床试验的 12 个月结果。
J Neurol. 2010 Jan;257(1):91-7. doi: 10.1007/s00415-009-5275-3. Epub 2009 Aug 1.
6
Early treatment with alglucosidase alpha prolongs long-term survival of infants with Pompe disease.用阿糖苷酶α进行早期治疗可延长庞贝病婴儿的长期生存期。
Pediatr Res. 2009 Sep;66(3):329-35. doi: 10.1203/PDR.0b013e3181b24e94.
7
Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease.在患有晚发型庞贝病的婴幼儿和儿童中使用阿糖苷酶α进行长期治疗后的临床结果。
Genet Med. 2009 Mar;11(3):210-9. doi: 10.1097/GIM.0b013e31819d0996.
8
Monitoring autophagy in lysosomal storage disorders.溶酶体贮积症中的自噬监测
Methods Enzymol. 2009;453:417-49. doi: 10.1016/S0076-6879(08)04021-4.
9
Lysosomal disorders: from storage to cellular damage.溶酶体疾病:从储存到细胞损伤
Biochim Biophys Acta. 2009 Apr;1793(4):684-96. doi: 10.1016/j.bbamcr.2008.12.001. Epub 2008 Dec 8.
10
Therapeutic approaches in glycogen storage disease type II/Pompe Disease.糖原贮积病II型/庞贝病的治疗方法。
Neurotherapeutics. 2008 Oct;5(4):569-78. doi: 10.1016/j.nurt.2008.08.009.

婴儿与成人间庞贝病溶酶体和自噬病理优势的差异:对治疗的启示。

Differences in the predominance of lysosomal and autophagic pathologies between infants and adults with Pompe disease: implications for therapy.

机构信息

Arthritis and Rheumatism Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD 20892-1820, USA.

出版信息

Mol Genet Metab. 2010 Dec;101(4):324-31. doi: 10.1016/j.ymgme.2010.08.001. Epub 2010 Aug 7.

DOI:10.1016/j.ymgme.2010.08.001
PMID:20801068
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2991562/
Abstract

Pompe disease is a lysosomal storage disorder caused by the deficiency of acid alpha-glucosidase, the enzyme that degrades glycogen in the lysosomes. The disease manifests as a fatal cardiomyopathy and skeletal muscle myopathy in infants; in milder late-onset forms skeletal muscle is the major tissue affected. We have previously demonstrated that autophagic inclusions in muscle are prominent in adult patients and the mouse model. In this study we have evaluated the contribution of the autophagic pathology in infants before and 6 months after enzyme replacement therapy. Single muscle fibers, isolated from muscle biopsies, were stained for autophagosomal and lysosomal markers and analyzed by confocal microscopy. In addition, unstained bundles of fixed muscles were analyzed by second harmonic imaging. Unexpectedly, the autophagic component which is so prominent in juvenile and adult patients was negligible in infants; instead, the overwhelming characteristic was the presence of hugely expanded lysosomes. After 6 months on therapy, however, the autophagic buildup becomes visible as if unmasked by the clearance of glycogen. In most fibers, the two pathologies did not seem to coexist. These data point to the possibility of differences in the pathogenesis of Pompe disease in infants and adults.

摘要

庞贝病是一种溶酶体贮积症,由酸性α-葡萄糖苷酶缺乏引起,该酶在溶酶体中降解糖原。这种疾病在婴儿中表现为致命性的心肌病和骨骼肌肌病;在较温和的晚发性形式中,骨骼肌是主要受影响的组织。我们之前已经证明,在成年患者和小鼠模型中,肌肉中的自噬包含物很明显。在这项研究中,我们评估了酶替代治疗前和治疗后 6 个月婴儿的自噬病理变化。从肌肉活检中分离出的单个肌纤维,用自噬体和溶酶体标记物染色,并通过共聚焦显微镜进行分析。此外,还通过二次谐波成像分析了未经染色的固定肌肉束。出乎意料的是,在青少年和成年患者中如此明显的自噬成分在婴儿中微不足道;相反,压倒性的特征是存在巨大扩张的溶酶体。然而,经过 6 个月的治疗后,自噬堆积变得可见,就好像糖原的清除使它暴露出来。在大多数纤维中,这两种病理似乎不会共存。这些数据表明婴儿和成人中庞贝病的发病机制可能存在差异。